Navigation Links
Sanofi-aventis Announces Second Quarter 2009 Results
Date:7/29/2009

------- ---- -------- Other Vaccines 59 +76.7% 98 +33.8% --------------- ----- ------- ---- -------- TOTAL 712 -0.8% 1,339 +3.7% --------------- ----- ------- ---- --------

* Seasonal and pandemic influenza vaccines

**+3.3% for the quarter and +27.4% for the first half excluding H5N1 vaccines

Second-quarter sales at Sanofi Pasteur MSD (not consolidated by sanofi-aventis), the joint venture with Merck & Co in Europe, were down 14.9% on a reported basis at euro 233 million. Sales of Gardasil((R)), for the prevention of papillomavirus infections (a major cause of cervical cancer), were down 27.4% at euro 108 million. This decrease was due to extensive catch-up campaigns in the prior year. Excluding Gardasil((R)), sales of the rest of the portfolio were stable. First-half sales at Sanofi Pasteur MSD were down 11.8% on a reported basis at euro 487 million.

Net sales by geographic region

                                 Change at            Change at
                                 constant             constant
                        Q2 2009  exchange    H1 2009   exchange
    Millions of euros net sales   rates     net sales   rates
    ----------------- ---------  --------   ---------- --------
    Europe               3,079      +4.6%      6,027     +1.8%
    ---------           ------    ------       -----     ----
     of which
      Eastern
      Europe               439     +37.5%        799    +27.0%
    ---------           ------    ------       -----     ----
    United States        2,438      +5.4%       4,733    -0.1%
    -------------       ------    ------       -----     ----
    Other Countries      1,921     +11.2%       3,785    +9.4%
    ---------------      -----     -
'/>"/>
SOURCE sanofi-aventis
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27

Related biology technology :

1. Sanofi-aventis Announces Settlement of Average Wholesale Price Civil Suits With the U.S. Department of Justice Relating to Anzemet(R)
2. Shareholder Class Action Filed Against Sanofi-Aventis by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
3. Sanofi-aventis SoloSTAR(R) Insulin Pen for Lantus and Apidra Receives the Prestigious GOOD DESIGN Award
4. ThalesNano Inc. and sanofi-aventis R&D Collaborate on Continuous Process Chemistry in Order to Dramatically Reduce Drug Realization Time
5. RainDance Technologies Signs a Collaboration Agreement with sanofi-aventis and Louis Pasteur University to Launch dScreen Consortium within ALSACE BIOVALLEY cluster
6. AEterna Zentaris and Sanofi-Aventis Sign a Development, Commercialization and Licensing Agreement for Cetrorelix in Benign Prostatic Hyperplasia
7. BioWa Announces License of POTELLIGENT(R) Technology to sanofi-aventis
8. Sanofi-aventis U.S. to Acquire Oral Chronic Lymphocytic Leukemia Treatment
9. Sanofi-aventis U.S. Announces Settlement of Medicaid Best Price Investigation
10. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
11. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/27/2014)... October 27, 2014 Ryan Carfley , ... month to sit down with Bryan Hamilton, the publisher of ... to discuss talent in the Research Triangle region of North ... were highlighted at the roundtable include the role of ... significance of work/life balance and the unique role that Millennials ...
(Date:10/27/2014)... The Italian company Roadrunnerfoot ... sell its artificial "lower limb", after the German ...      (Photo: http://photos.prnewswire.com/prnh/20141027/713097 ) , ... definitive judgement has arrived: Roadrunnerfoot, the small Italian ... hi-tech prostheses with composite materials, has won against ...
(Date:10/27/2014)... , Oct. 27, 2014 Kalorama Information ... recent Ebola concern in the United States ... virus.  The healthcare market researcher said the FDA,s Emergency Use ... vitro diagnostic tests for the detection of the Ebola ... proved useful.  Kalorama routinely assess the IVD industry and ...
(Date:10/27/2014)... 27, 2014 New Q4-2014 incentives ... , an industry leading unified communication and collaboration ... agents to deliver cloud-based audio and web/video conferencing ... , With SoundConnect’s Q4 incentive partners ... and/or web conferencing licenses sold, now through December ...
Breaking Biology Technology:Personify's Ryan Carfley Talks Recruiting with Triangle Business Journal, RPG Solutions 2Personify's Ryan Carfley Talks Recruiting with Triangle Business Journal, RPG Solutions 3Italian Lower Limb Prosthesis Company Wins Lawsuit Against German Giant Ottobock 2Kalorama: PCR The Go-to Test in Ebola Fight 2Kalorama: PCR The Go-to Test in Ebola Fight 3SoundConnect Unveils Q4 Partner Incentives 2
... Forest Laboratories, Inc.,(NYSE: FRX ) and H. ... Court,of Appeals for the Federal Circuit has affirmed a ... the District of Delaware which determined that,the U.S. patent ... upheld the injunction preventing Ivax/Teva,s proposed generic,product launch, thereby ...
... a Proven Leader at Driving Growth, SAN FRANCISCO, ... equity firm that focuses on investments in selected segments,of ... software, today announced the appointment of Michael L. Hurt,to ... Mr. Hurt, CEO,of Altra Industrial Motion (Nasdaq: AIMC ...
... Diagnostic Systems Installs CTLM(R) in Tianjin, China, ... Inc., (OTC Bulletin Board: IMDS) a pioneer in ... CT Laser Mammography,(CTLM(R)) system at the Tianjin Medical ... center in China. (Logo: http://www.newscom.com/cgi-bin/prnh/20040412/IMDSLOGO ...
Cached Biology Technology:Forest Laboratories Announces Federal Appeals Court Upholds Lexapro(R) Patent Decision 2Genstar Names Michael Hurt to Its Strategic Advisory Board 2Largest Asian Cancer Hospital to Evaluate New CT Laser Breast Imaging System 2Largest Asian Cancer Hospital to Evaluate New CT Laser Breast Imaging System 3
(Date:10/29/2014)... as ,facultative, form part—together with other cells—of tissues and ... from the others. However, they have a very special ... cells again. This phenomenon is something that happens in ... tissue growth, thus allowing the regeneration of the organ ... the underlying mechanism that allows these cells to retain ...
(Date:10/29/2014)... organisms in the living world compete with members ... in how much they invest into their competitive ... to get access to high-quality resources, while others ... of the lower-quality resources that are left over ... animal and human societies seems to fluctuate considerably ...
(Date:10/29/2014)... of kidney cancer patients in Europe sheds light on ... an apparent link between exposure to aristolochic acid and ... research, by an international team led by scientists from ... Montreal, underscores the importance of investigating possible sources of ... of the Aristolochia genus, also has been suspected of ...
Breaking Biology News(10 mins):A mechanism that allows a differentiated cell to reactivate as a stem cell revealed 2Evolution of competitiveness 2Evolution of competitiveness 3Study sheds light on genetic architecture of kidney cancer 2Study sheds light on genetic architecture of kidney cancer 3
... northern Australia, finding black holes in space, to making ... work of some of its scientists and staff today ... awarded each year to staff of the CSIRO who ... 1985, the CSIRO Medals have been presented to a ...
... study published in Science and reviewed by F1000 ... brains have the amazing ability to be energy efficient. ... potentials, by controlling the flow of positive sodium and potassium ... equilibrium after an action potential requires energy. The ...
... 2009 Areas of turf-forming species created and maintained ... i.e. "urban grasslands" are an extremely common, but poorly ... grasslands in the U.S. and many receive high rates ... lakes, and estuaries and emissions of greenhouse gases such ...
Cached Biology News:CSIRO medal winners 2CSIRO medal winners 3Nitrogen mysteries in urban grasslands 2Nitrogen mysteries in urban grasslands 3
RABBIT ANTI SRC-RSV...
sodium channel, nonvoltage-gated 1 alpha,...
4-Hydroxy-3-nitrophenylacetyl hapten is conjugated to SGG (Sheep gamma globulin) lysine through amide bonds. This product is homologous to NP-BSA....
MOUSE ANTI HUMAN B-CELLS (FMC7):FITC Immunogen: HRIK cells - Human B-Lymphoblastoid line...
Biology Products: